Is Xeris Biopharma Holdings Inc (NASDAQ:XERS) A Better Buy Than Others After A 77.78% Rise In This Year?
In last trading session, Xeris Biopharma Holdings Inc (NASDAQ:XERS) saw 0.89 million shares changing hands with its beta currently measuring 1.83. Company’s recent per share